4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.42

 -0.05 (-10.526%)
ASX:Live
08/08/2025 04:10:26 PM
Volume Spike HALO Price Momentum HALO Ords HALO Momentum HALO Earnings Momentum +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

4DX Overview

4DX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About 4DX

Website

4DMedical Ltd

Telephone

61.3.9545.5940

Address

700 Swanston Street Level 7 Carlton, Victoria (VIC) 3053

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$183.89M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.22 - 0.7

Trade Value (12mth)

AU$97,072.00

1 week

55.74%

1 month

90%

YTD

-1.04%

1 year

7.95%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

18.60%

EBITDA Margin

%

Operating Cashflow

-$31m

Free Cash Flow Return

-40.90%

ROIC

-47.70%

Interest Coverage

-167.30

Quick Ratio

1.70

Other Data

Shares on Issue (Fully Dilluted)

413m

HALO Sector

Technology

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.03

4DX Announcements

Latest Announcements

Date Announcements

31 July 25

Quarterly Activity Report and Appendix 4C

×

Quarterly Activity Report and Appendix 4C

31 July 25

Proposed issue of securities - 4DX

×

Proposed issue of securities - 4DX

31 July 25

4DMedical secures $10m strategic investment from Pro Medicus

×

4DMedical secures $10m strategic investment from Pro Medicus

28 July 25

Proposed issue of securities - 4DX

×

Proposed issue of securities - 4DX

18 July 25

4DMedical renews 3 year contract with University of Michigan

×

4DMedical renews 3 year contract with University of Michigan

08 July 25

Change of Director's Interest Notice - AF

×

Change of Director's Interest Notice - AF

03 July 25

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

03 July 25

Notification of cessation of securities - 4DX

×

Notification of cessation of securities - 4DX

03 July 25

Cleansing Notice

×

Cleansing Notice

17 June 25

4DMedical contract with Stanford, includes CTVQ

×

4DMedical contract with Stanford, includes CTVQ

11 June 25

Olympus launches new SeleCT Screening campaign

×

Olympus launches new SeleCT Screening campaign

10 June 25

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

30 May 25

Cleansing Notice

×

Cleansing Notice

29 May 25

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

27 May 25

Investor Presentation - FDA Submission for CTVQ

×

Investor Presentation - FDA Submission for CTVQ

26 May 25

4DMedical files FDA submission for CTVQ

×

4DMedical files FDA submission for CTVQ

05 May 25

4DMedical wins commercial contract with Intermountain Health

×

4DMedical wins commercial contract with Intermountain Health

02 May 25

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

02 May 25

Top 20 Option Holders & Distribution Schedule

×

Top 20 Option Holders & Distribution Schedule

01 May 25

Results of EGM

×

Results of EGM

29 April 25

Quarterly Activity Report and Appendix 4C for Q3 FY2025

×

Quarterly Activity Report and Appendix 4C for Q3 FY2025

24 April 25

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

24 April 25

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

16 April 25

Supplementary Prospectus

×

Supplementary Prospectus

16 April 25

Revised Target Market Determination

×

Revised Target Market Determination

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.03%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.42.
The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$0.70.
The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.22.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.
4DMedical Ltd (4DX:ASX) is classified in the Technology.
The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .
The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.42.
The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$0.70.
The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.22.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.
4DMedical Ltd (4DX:ASX) is classified in the Technology.
The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.